NAKAMURA Yoichi 中村洋一

Researcher Number	20432974
External Links
Affiliation (Current)	2025: 地方独立行政法人栃木県立がんセンター(研究所), 研究所－がん医療研究, 研究医師 2025: 地方独立行政法人栃木県立がんセンター(研究所), 研究所, 研究医師
Affiliation (based on the past Project Information) *help	2017: 栃木県立がんセンター, 呼吸器内科, 医長 2015: 長崎大学, 医歯薬学総合研究科(医学系), 講師 2014: 長崎大学, 病院(医学系), 講師 2012 – 2013: 長崎大学, 医歯(薬)学総合研究科, 講師 2012: 長崎大学, 医歯薬総合研究科, 講師 … More 2011: 長崎大学, 大学院・医歯薬学総合研究科, 講師 2009 – 2010: 長崎大学, 病院, 助教 2007 – 2008: Nagasaki University, 医学部・歯学部附属病院, 助教 Less
Review Section/Research Field	Principal Investigator Laboratory medicine / Applied pharmacology Except Principal Investigator Tumor therapeutics / Respiratory organ internal medicine
Keywords	Principal Investigator 非小細胞肺癌 / 肺癌化学療法 / 個別化医療 / 個別化治療 / オーダーメイド治療 / 遺伝子変異多型 / 上皮増殖因子受容体 / 遺伝子検査学 / 分子標的薬 / トラフ値 … More / 血中濃度 / 上皮成長因子受容体阻害薬 / 分子標的治療 / 肺癌 / 臨床薬理学 … More Except Principal Investigator 二ボルマブ / 免疫療法 / 症例集積開始 / 効果予測因子の検出 / 免疫複合体解析 / 症例集積 / 倫理委員会承認 / プロトコール作成 / イムノコンプレキソーム法 / 効果予測因子 / ニボルマブ / 抗PD-1抗体 / 免疫チェックポイント阻害剤 / 肺がん / 上皮成長因子受容体阻害薬 / 肺サーファクタント蛋白 / 上皮成長因子受容体阻害 / 個別化治療 / 分子標的治療 / 肺癌 Less

Discovery of effect predictor of anti-PD-1 antibody in lung cancer
- Principal Investigator
  
  IKEDA Takaya
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Nagasaki University
Analysis of mRNA level of the treatment resistance related proteins in unfixed lung cancer biopsy specimens obtained by core-biopsy.Principal Investigator
- Principal Investigator
  
  NAKAMURA Yoichi
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  Nagasaki University
ESTABLISH THE INDIVIDUALIZED TREATMENT ON LUNG ADENOCARCINOMA USINGTHE EGFR GENE MUTATION ANALYSIS.Principal Investigator
- Principal Investigator
  
  NAKAMURA Yoichi
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  Nagasaki University
POSSIBILITY OF PERSONALIZED TREATMENT IN PATIENTS WITH NON- SMALL CELL LUNG CANCER BY MONITERING OF SERUM CONSENTRATION OF GEFITINIBPrincipal Investigator
- Principal Investigator
  
  NAKAMURA Yoichi
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Nagasaki University
Establishment of personalized therapy with epidermal growth factor receptor inhibitors for lung cancer based on the inhibitory effects of surfactant secretion
- Principal Investigator
  
  SODA Hiroshi
- Project Period (FY)
  2007 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Nagasaki University

All 2015 2014 2013 2012 2011 2010 2009 2008 2007 Other

All Journal Article Presentation Book

[Book] 抗悪性腫瘍治療薬マニュアル2007
- Author(s)
  中村ら
- Total Pages
  485
- Publisher
  中外医学社
- Data Source
  KAKENHI-PROJECT-19590538
[Book] 抗悪性腫瘍治療薬マニュアル2007
- Author(s)
  中村洋一
- Total Pages
  485
- Publisher
  中外医学社
- Data Source
  KAKENHI-PROJECT-19590538
[Journal Article] Heterogeneity of EGFR mutations in a patient treated with gefitinib as neo-adjuvant chemotherapy.2015
- Author(s)
  Mizoguchi K, Nakamura Y, Abe K, Takemoto S, Motoshima K, Ogawara D, Nakatomi K, Fukuda M, Fukuoka J, Kohno, S.
- Journal Title
  
  Cancer Treat Commun
  
  Volume: 4 Pages: 117-120
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25460691
[Journal Article] Chemotherapy2015
- Author(s)
  Kasai T, Nakamura Y, Fukuda M, Kitazaki T, Nagashima S, Takatani H, Nakano H, Nakatomi K, Ikeda T, Yamaguchi H, Tsukamoto K, Oka M, Kohno S.
- Journal Title
  
  Phase II study of S-1 for previously untreated elderly patients with advanced non-small cell lung cancer.
  
  Volume: 61 Issue: 2 Pages: 93-98
- DOI
  10.1159/000441486
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-25460691
[Journal Article] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer2014
- Author(s)
  Ikeda T, Fukuda M, Nakamura Y, et al.
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 74 Issue: 3 Pages: 497-502
- DOI
  10.1007/s00280-014-2527-4
- NAID
  120006986379
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25460691
[Journal Article] Secondary EML4-ALK-positive lung adenocarcinoma in a patient previously treated for acute lymphoblastic leukemia in childhood: a case report.2014
- Author(s)
  Nakamura Y et al.
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 44 Issue: 6 Pages: 593-596
- DOI
  10.1093/jjco/hyu028
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25460691, KAKENHI-PROJECT-26461155
[Journal Article] Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer2012
- Author(s)
  Fukuda M, Nakamura Y, Kohno S
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 70 Pages: 645-51
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer2012
- Author(s)
  Takatani H, Nakamura Y, Nakatomi K, et al.
- Journal Title
  
  Clin Lung Cancer
  
  Volume: 13 Pages: 347-51
- NAID
  120006985538
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Direct comparison of 3 PCR methods in detecting EGFR mutations in patients with advanced non-small-cell lung cancer.2012
- Author(s)
  Ikeda T, Nakamura Y, Nakatomi K, et al.
- Journal Title
  
  Clin Lung Cancer
  
  Volume: 13 Issue: 5 Pages: 369-374
- DOI
  10.1016/j.cllc.2012.01.008
- NAID
  120006985537
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer.2012
- Author(s)
  Fukuda M, Nakamura Y, Kohno S, et al.
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 70 Issue: 5 Pages: 645-651
- DOI
  10.1007/s00280-012-1952-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Direct comparison of 3 PCR methods in detecting EGFR mutations in patients with advanced non-small-cell lung cancer2012
- Author(s)
  Ikeda T, Nakamura Y, Nakatomi K, et al.
- Journal Title
  
  Clin Lung Cancer
  
  Volume: 13 Pages: 369-74
- NAID
  120006985537
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer.2012
- Author(s)
  Takatani H, Nakamura Y, Nakatomi K, et al.
- Journal Title
  
  Clin Lung Cancer
  
  Volume: 13 Issue: 5 Pages: 347-351
- DOI
  10.1016/j.cllc.2011.11.007
- NAID
  120006985538
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer : association of UGT1A1^*6 and UGT1A1^*27 with severe neutropenia2011
- Author(s)
  Nakamura Y
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 6 Issue: 1 Pages: 121-217
- DOI
  10.1097/jto.0b013e318200e4e8
- NAID
  120006984817
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer2011
- Author(s)
  Yamaguchi H, Nakamura Y, Nakatomi K, Net al
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 67 Pages: 331-8
- NAID
  120006984543
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer : association of UGT1A1*6 and UGT1A1*27 with severe neutropenia.2011
- Author(s)
  Nakamura Y
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 6 Pages: 121-127
- NAID
  120006984817
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia2011
- Author(s)
  Nakamura Y, Soda H, Nakatomi K, et al.
- Journal Title
  
  J Thorac Oncol
  
  Volume: 6 Pages: 121-7
- NAID
  120006984817
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Superior vena cava syndrome caused by adult T-cell leukemia/lymphoma: a case report2011
- Author(s)
  Ikeda T, Nakamura Y, Kohno S, et al
- Journal Title
  
  Acta Med Nagasaki
  
  Volume: 56 Pages: 59-61
- NAID
  110008767595
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Pharmacokinetics of gefitinib predicts antitumor activity for advanced non-small cell lung cancer2010
- Author(s)
  Nakamura Y, Sano K, Soda H, et al.
- Journal Title
  
  J Thorac Oncol
  
  Volume: 5 Pages: 1404-9
- NAID
  120006984946
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Interstitial pneumonia probably associated with sorafenib treatment: an alert of an adverse event2010
- Author(s)
  Ide S Soda H, Hakariya T, Takemoto S, Ishimoto H, Tomari S, Sawai T, Nagashima S, Furukawa M, Nakamura Y, Kohno S
- Journal Title
  
  Lung Cancer 67
  
  Pages: 248-250
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590901
[Journal Article] Interstitial pneumonia probably associated with sorafenib treatment: An alert of an adverse event.2010
- Author(s)
  Ide S, Soda H, Nakamura Y, et al.
- Journal Title
  
  Lung Cancer
  
  Volume: 67 Pages: 248-50
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Efficacy and safety of amrubicin hyd rochoride for the treatment of relapsed small cell lung cancer2010
- Author(s)
  Ogawara D, Fukuda M, Nakamura Y, et al
- Journal Title
  
  Cancer Manag Res
  
  Volume: 2 Pages: 191-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Pharmacokinetics of gefitinib predicts antitumor activity for advanced non-small cell lung cancer.2010
- Author(s)
  Nakamura Y
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 5 Pages: 1404-1409
- NAID
  120006984946
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590531
[Journal Article] Spontaneous remission of a non-small cell lung cancer possibly caused by anti-NY-ESO-1 immunity2009
- Author(s)
  Nakamura Y
- Journal Title
  
  Lung Cancer 65
  
  Pages: 119-122
- NAID
  120006984535
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590901
[Journal Article] Gefitinib increases serum concentrations of oral irinotecan and SN-38 without increasing the biliary concentration of SN-38 in rats2008
- Author(s)
  Nakamura Y, Stake K, Sano K, Ito A, Yoshikawa M, Ikegami Y, Yoshida H, Nakano H, Oka M, Sawada S, Soda H, Kohno S
- Journal Title
  
  Chemotherapy 54
  
  Pages: 485-491
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590901
[Journal Article] Gefitinib increases serum concentrations of oral irinotecan and SN- 38 withoutincreasing the biliary concentration of SN- 38 in rats2008
- Author(s)
  Nakamura Y, Satake K, Sano K, et.al.
- Journal Title
  
  Chemotherapy 54
  
  Pages: 485-491
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590538
[Journal Article] Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule2008
- Author(s)
  Nakano H, Soda H, Takasu M, Tomonaga N, Yamaguchi H, Nakatomi K, Fujino S, Hayashi T, Nakamura Y, Tsukamoto K, Kohno S
- Journal Title
  
  Lung Cance 60
  
  Pages: 136-140
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590901
[Journal Article] Gefitinib increases serum concentrations of oral irinotecan and SN-38 withoutincreasing the biliary concentration of SN-38 in rats.2008
- Author(s)
  Nakamura Y
- Journal Title
  
  Chemotherapy 54
  
  Pages: 485-491
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590538
[Journal Article] Nagasaki Thoracic Oncology Group : Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non- small cell lung cancer2008
- Author(s)
  Tomonaga N, Nakamura Y, Soda H,et.al.
- Journal Title
  
  Cancer Chemothe Pharmacol 62
  
  Pages: 43-49
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590538
[Journal Article] Stepwise progression from ground-glass opacity towards invasive adenocarcinoma: long-term follow-up of radiological findings2008
- Author(s)
  Soda H, Nakamura Y, Nakatomi K, Tomonaga N, Yamaguchi H, Nakano H, Nagashima S, Anami M, Hayashi T, Tsukamoto K, Kohno S
- Journal Title
  
  Lung Cancer 60
  
  Pages: 298-301
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590901
[Journal Article] Stepwise progression from ground- glass opacity towards invasive adenocarcinoma : long- term follow- up of radiological findings2008
- Author(s)
  Soda H, Nakamura Y, Nakatomi K,et.al.
- Journal Title
  
  Lung Cancer 60
  
  Pages: 298-301
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590538
[Journal Article] Methylation status of breast cancer resistance protein detected by methylation- specific polymerase chain reaction analysis is correlated inversely with its expression in drug- resistant lung cancer cells2008
- Author(s)
  Nakano H, Nakamura Y, Soda H, et.al.
- Journal Title
  
  Cancer 112
  
  Pages: 1122-1130
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590538
[Journal Article] Irinotecan and cisplatin with concurrent split- course radiotherapy in locally advanced nonsmall-cell lung cancer2007
- Author(s)
  Fukuda M, Soda H, Nakamura Y, et.al.
- Journal Title
  
  a multiinstitutional phase 2 study. Cancer 110
  
  Pages: 606-613
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590538
[Journal Article] Different epidermal growth factor receptor gene mutations in a patient with two synchronous lung cancers2007
- Author(s)
  Nakano H, Soda H, Nakamura Y, Uchida K, Takasu M, Nakatomi K, Izumikawa K, Hayashi T, Nagayasu T, Tsukamoto K, Kohno S
- Journal Title
  
  Clin Lung Cancer 8
  
  Pages: 562-564
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590901
[Journal Article] Different epidermal growth factor receptor gene mutations in a patient with 2 synchronous lung cancers2007
- Author(s)
  Nakano H, Soda H, Nakamura Y, et.al.
- Journal Title
  
  Clin Lung Cancer 8
  
  Pages: 562-564
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590538
[Journal Article] Phase I study of irinotecan and gemcitabine in previously untreated patients with advanced non- small cell lung cancer2007
- Author(s)
  Takatani H, Soda H, Nakamura Y,et.al.
- Journal Title
  
  Jpn J Clin Oncol 37
  
  Pages: 353-357
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590538
[Journal Article] Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer
- Author(s)
  Yamaguchi H, Soda H, Nakamura Y, Takasu M, Tomonaga N, Nakano H, Doi S, Nakatomi K, Nagashima S, Takatani H, Fukuda M, Hayashi T, Tsukamoto K, Kohno S
- Journal Title
  
  Cancer Chemother Pharmacol (in press)
- NAID
  120006984543
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590901
[Presentation] Detection of EML4-ALK Fusion Gene by Using Nested Long-Ranged Polymerase Chain Reaction.2015
- Author(s)
  Takemoto S, Nakamura Y, Yamaguchi H, Nakatomi K, et al.
- Organizer
  World Conference on Lung Cancer 2015
- Place of Presentation
  Denver, USA
- Year and Date
  2015-09-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25460691
[Presentation] Phase II Trial of Paclitaxel, Irinotecan, and Bevacizumab for Patients with Untreated NSCLC Overexpressed ERCC1 mRNA2015
- Author(s)
  Nakamura Y, Yamaguchi H, Nakatomi K, et al.
- Organizer
  World Conference on Lung Cancer 2015
- Place of Presentation
  Denver, USA
- Year and Date
  2015-09-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25460691
[Presentation] ゲフィチニブの薬物動態と抗腫瘍活性および有害事象との相関についての解析2014
- Author(s)
  中村洋一
- Organizer
  第73階日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2014-10-25
- Data Source
  KAKENHI-PROJECT-25460691
[Presentation] Phase I/ II Study of Amrubicin and Nedaplatin in Patients with Untreated, Advanced Non Small-cell Lung Cancer2013
- Author(s)
  中村洋一
- Organizer
  18th Congress of the Asian Pacific Society of Respirology
- Place of Presentation
  Pacifico Yokohama, Yokohama, Japan
- Data Source
  KAKENHI-PROJECT-25460691
[Presentation] Phase I/II study of amrubicin and nedaplatin in patients with untreated, advanced non small-cell lung cancer.2012
- Author(s)
  Senju H, Nakamura Y, Ogawara D, et al.
- Organizer
  The 12th American Society of Clinical Oncology (12th ASCO, Chicago)
- Place of Presentation
  Chicago
- Data Source
  KAKENHI-PROJECT-22590531
[Presentation] A Clinical Study of 34 Malignant pleural mesothelioma patients treated with pemetrexed from Nagasaki Thoracic Oncology Group.2012
- Author(s)
  Dotsu Y, Nakamura Y, Fukuda M, et al.
- Organizer
  3rd International Thymic Malignancy Interest Group Conference and the 5th Asia Pacific Lung Cancer Conference (APLCC/ITMIG)
- Place of Presentation
  Fukuoka
- Data Source
  KAKENHI-PROJECT-22590531
[Presentation] Analysis of intra-tumor heterogeneity of EGFR mutations in mixed-type lung adenocarcinoma.2011
- Author(s)
  Tomonaga N, Nakamura Y, Yamaguchi H, et al
- Organizer
  The 14thInternational Association for the Study of Lung Cancer (14th IASLC)
- Place of Presentation
  Amsterdam, Holland
- Year and Date
  2011-07-05
- Data Source
  KAKENHI-PROJECT-22590531
[Presentation] 肺腺癌におけるEGFR遺伝子変異の同一腫瘍内での遺伝子変異多型分布の解析2011
- Author(s)
  中村洋一、朝永七枝、山口博之、その他
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-05
- Data Source
  KAKENHI-PROJECT-22590531
[Presentation] 肺腺癌におけるEGFR遺伝子変異の同一腫瘍内での遺伝子変異多型分布の解析2011
- Author(s)
  中村洋一
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2011-10-05
- Data Source
  KAKENHI-PROJECT-22590531
[Presentation] The analysis of EGFR genetic heterogeneity on mixed adenocarcinoma of the lung.2010
- Author(s)
  Tononaga N, Nakatomi K, Nakamura Y, et al
- Organizer
  01th American Association for Cancer Research (101thAACR)
- Place of Presentation
  Washington DC, USA
- Year and Date
  2010-04-19
- Data Source
  KAKENHI-PROJECT-22590531
[Presentation] 肺癌におけるEGFR遺伝子変異検出方法の比較2010
- Author(s)
  中村洋一
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪国際会議場(大阪市)
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-22590531
[Presentation] Pharmacokinetics of gefitinib predicts the antitumor activity for NSCLC patients : adding the analysis of EGFR-mutations2008
- Author(s)
  中村、佐野、早田ら
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-28
- Data Source
  KAKENHI-PROJECT-19590538
[Presentation] ゲフィチニブ血中濃度の肺癌患者における抗腫瘍活性に与える影響EGFR遺伝子解析の追加報2008
- Author(s)
  中村洋一, 佐野和美, 早田宏, 塚元和弘, 高谷洋長島聖二, 福田実, 山口博之, 土井誠志, 中富克己, 岡三喜男, 河野茂
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-19590901
[Presentation] Gefitinib効果予測因子としての血清SP-Dの検討2008
- Author(s)
  山口博之, 中村洋一, 朝永七枝, 中野浩文, 土井誠志, 中富克己, 早田宏, 塚元和弘, 河野茂
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-19590901
[Presentation] Pharmacokinetics of gefitinib predicts the antitumor activity for NSCLC patients : adding the analysis of EGFR-mutations.2008
- Author(s)
  Nakamura Y
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-28
- Data Source
  KAKENHI-PROJECT-19590538
[Presentation] 肺腺癌のEGFR変異とgefitinibによる治療効果との相関解析2007
- Author(s)
  高巣峰代, 卜部奏, 小林奨, 中野浩文, 山口博之, 中富克己, 中村洋一, 橋口浩二, 福田正明, 福田実, 木下明敏, 岡三喜男, 河野茂, 塚元和弘
- Organizer
  第48回日本肺癌学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-19590901
[Presentation] Pharmacokinetics of gefitinib predicts the antitumor activity for advanced non-small cell lung cancer2007
- Author(s)
  Iida T, Nakamura Y, Fukuda M, Takatani H, Nagashima S, Kinoshita A, Fukuda M, Soda H
- Organizer
  12th World Conference on Lung Cancer
- Place of Presentation
  Seoul
- Data Source
  KAKENHI-PROJECT-19590901
[Presentation] Gefitinib効果予測因子としての血清SP-Dの検討2007
- Author(s)
  山口博之, 中村洋一, 朝永七枝, 中野浩文, 中富克己, 早田宏, 河野茂
- Organizer
  第48回日本肺癌学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-19590901
[Presentation] Pharmacokinetics of gefitinib predicts the antitumor activity for advanced non- small cell lung cancer2007
- Author(s)
  Fukuda M, Nakamura Y, Sano K, et.al.
- Organizer
  14th European Cancer Conference
- Place of Presentation
  Barcelona
- Year and Date
  2007-09-25
- Data Source
  KAKENHI-PROJECT-19590538
[Presentation] Pharmacokinetics of gefitinib predicts the antitumor activity for advanced non- small cell lung cancer (NSCLC)
- Author(s)
  Iida T, Nakamura Y, Soda H, et.al.
- Organizer
  12th World Conference on Lung Cancer
- Place of Presentation
  Seoul
- Data Source
  KAKENHI-PROJECT-19590538

1. SODA Hiroshi (60244042)

# of Collaborated Projects: 3 results

# of Collaborated Products: 18 results
2. NAKATOMI Katsumi (90457531)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
3. NAGASHIMA Seiji (00646672)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. FUKUDA Minoru (50388930)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
5. IKEDA Takaya (00773871)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. OHYAMA Kaname (50437860)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. OKA Mikio

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

NAKAMURA Yoichi 中村 洋一

Research Projects

Research Products

Co-Researchers

Discovery of effect predictor of anti-PD-1 antibody in lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of mRNA level of the treatment resistance related proteins in unfixed lung cancer biopsy specimens obtained by core-biopsy.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

ESTABLISH THE INDIVIDUALIZED TREATMENT ON LUNG ADENOCARCINOMA USINGTHE EGFR GENE MUTATION ANALYSIS.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

POSSIBILITY OF PERSONALIZED TREATMENT IN PATIENTS WITH NON- SMALL CELL LUNG CANCER BY MONITERING OF SERUM CONSENTRATION OF GEFITINIBPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Establishment of personalized therapy with epidermal growth factor receptor inhibitors for lung cancer based on the inhibitory effects of surfactant secretion

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 抗悪性腫瘍治療薬マニュアル2007

Author(s)

Total Pages

Publisher

Data Source

[Book] 抗悪性腫瘍治療薬マニュアル2007

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Heterogeneity of EGFR mutations in a patient treated with gefitinib as neo-adjuvant chemotherapy.2015

Author(s)

Journal Title

Data Source

[Journal Article] Chemotherapy2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer2014

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Secondary EML4-ALK-positive lung adenocarcinoma in a patient previously treated for acute lymphoblastic leukemia in childhood: a case report.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer2012

Author(s)

Journal Title

Data Source

[Journal Article] Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer2012

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Direct comparison of 3 PCR methods in detecting EGFR mutations in patients with advanced non-small-cell lung cancer.2012

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer.2012

NAKAMURA Yoichi 中村洋一

[Journal Article] Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer : association of UGT1A1^6 and UGT1A1^27 with severe neutropenia2011

[Journal Article] Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer : association of UGT1A16 and UGT1A127 with severe neutropenia.2011

[Journal Article] Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A16 and UGT1A127 with severe neutropenia2011